Literature DB >> 20086294

Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease.

Jayashree Shanker1, Ganapathy Perumal, Arindam Maitra, Veena S Rao, B K Natesha, Shibu John, Sridhar Hebbagodi, Vijay V Kakkar.   

Abstract

Elevated factor VII (FVII) level is a risk factor for coronary artery disease (CAD). We investigated the role of R353Q polymorphism in the F7 gene in 139 Indian families with CAD, comprising of 222 affected subjects, 105 unaffected subjects and 126 affected sibling pairs. Plasma per cent FVIIc activity (FVII.c activity) differed ignificantly across R353Q genotype (P < 0.0001). Frequency of subjects with RR and QQ genotypes were higher in 4th quartile and 1st quartile of FVII.c activity, respectively (P < 0.0001). F7 R353Q SNP was able to explain up to 7% of variation in FVII.c activity by regression analysis and an additive genetic component of variance of 28.04% by heritability analysis. Quantitative trait loci analysis showed suggestive linkage evidence of F7 SNP with per cent FVII.c activity (LOD score -1.82; P = 0.002). Individuals with RR and RQ genotypes carried an OR of 2.071 (95% c.i. = 1.506-2.850) and 2.472 (95% c.i. = 1.679-3.641), espectively, towards CAD risk. There was significant correlation of FVII.c activity with lipid markers, particularly among those with RR and RQ genotype after covariate adjustment. In conclusion, the F7 R353Q SNP appears to moderately influence plasma FVII.c activity and risk of CAD in Indians.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20086294     DOI: 10.1007/s12041-009-0042-x

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  24 in total

1.  Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese.

Authors:  Y Liu; C K Heng; N Saha; S Hong; P S Low
Journal:  Blood Coagul Fibrinolysis       Date:  2002-04       Impact factor: 1.276

2.  Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.

Authors:  F Bernardi; P Arcieri; R M Bertina; F Chiarotti; J Corral; M Pinotti; H Prydz; M Samama; P M Sandset; R Strom; V V Garcia; G Mariani
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

3.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study.

Authors:  A Lane; F Green; P Y Scarabin; V Nicaud; L Bara; S Humphries; A Evans; G Luc; J P Cambou; D Arveiler; F Cambien
Journal:  Atherosclerosis       Date:  1996-01-05       Impact factor: 5.162

6.  Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

Authors:  L V Rao; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 7.  Population-based distributions of haemostatic variables.

Authors:  T W Meade; W R North; R Chakrabarti; A P Haines; Y Stirling
Journal:  Br Med Bull       Date:  1977-09       Impact factor: 4.291

8.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

9.  Coagulation factor VII gene haplotypes, obesity-related traits, and cardiovascular risk in young women.

Authors:  A P Reiner; C S Carlson; M J Rieder; D S Siscovick; K Liu; W L Chandler; D Green; S M Schwartz; D A Nickerson
Journal:  J Thromb Haemost       Date:  2006-10-16       Impact factor: 5.824

10.  A review of the 'Statistical Analysis for Genetic Epidemiology' (S.A.G.E.) software package.

Authors:  Robert C Elston; Courtney Gray-McGuire
Journal:  Hum Genomics       Date:  2004-11       Impact factor: 4.639

View more
  3 in total

1.  Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.

Authors:  G Ken-Dror; F Drenos; S E Humphries; P J Talmud; A D Hingorani; M Kivimäki; M Kumari; K A Bauer; J H Morrissey; H A Ireland
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

2.  Novel network biomarkers profile based coronary artery disease risk stratification in Asian Indians.

Authors:  Rajani Kanth Vangala; Vandana Ravindran; Karthik Kamath; Veena S Rao; Hebbagodi Sridhara
Journal:  Adv Biomed Res       Date:  2013-07-30

3.  The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.

Authors:  A N Do; A I Lynch; S A Claas; E Boerwinkle; B R Davis; C E Ford; J H Eckfeldt; H K Tiwari; D K Arnett; M R Irvin
Journal:  J Hum Hypertens       Date:  2016-01-21       Impact factor: 3.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.